Key Takeaways Moderna’s mRNA flu vaccine worked better than the standard flu shot in a new trialIt showed 26.6% better protection in folks 50 and olderThe company said it will work with ...

The main reason for the downturn in Moderna’s stock is a significant drop in the demand for its COVID-19 vaccine.

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. said on Tuesday that Moderna has agreed to a true placebo-controlled trial of its new COVID-19 vaccine. While noting that he was ...

The Food and Drug administration has approved a new COVID-19 vaccine made by Moderna but with limits on who can use it.

The Trump administration has canceled $766 million awarded to drugmaker Moderna Inc. to develop a vaccine against potential pandemic influenza viruses, including H5N1 bird flu.

U.S. health officials are terminating a $590 million contract with Moderna Inc. to develop vaccines for bird flu, a major setback for the company that’s also facing additional government scrutiny ...

What could be hotter than Moderna getting in the Claudin18.2 race? How about pairing the mRNA vaccine with a solid tumor-targeting CAR-T?

Stay up to date on Moderna analyst ratings. How Are Analyst Ratings Determined? Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors.

Shares in Moderna (MRNA) rose smartly Thursday after the COVID-19 vaccine maker reported better-than-expected earnings and said it was in "active supply discussions" with the European Union ...

Moderna CEO Stephane Bancel testified before the Senate to defend boosting the price of Covid vaccines to $130. It's a reminder of how corrupt Big Pharma is.